Search Results

Go back Mary E. Schmidt, MD Board member President, Schmidt & Libby Health Advisory Group Associate Professor of Clinical Medicine, VCU Dr. Schmidt is the President of Schmidt and Libby Health Advisory Group. She is board-certified in infectious diseases and internal medicine, has a master’s degree in Public Health from John Hopkins Bloomberg School of Public Health, and is an associate professor of Clinical Medicine at Virginia Commonwealth University. She practiced her specialty of infectious diseases for 25 years and has many awards and honors including the Best Physicians in America. In addition, Dr. Schmidt has had several leadership positions. She was Chief of Staff at the Inova Fairfax Medical Campus from 2010 through 2013 where she led the quality and citizenship activities of 2,400 physicians. She was a member of the Command Center at Inova Fairfax Hospital for Disaster and Bioterrorism Events and a member of the Inova Health System Oversight Committee for the roll out of the Epic medical record system. Dr. Schmidt has also held the position of Director of Transplant Infectious Diseases for 6 years at Inova Fairfax Hospital where she focused on the medical care of immunocompromised individuals and excellence in the care of transplant patients. Previous Next

Go back Hoa T. Nguyen, PhD Board member Vice President, AMVI Partners, LLC Director of Phu Sa Trading Co;Ltd Mrs Hoa Nguyen is a professional in significant product development, marketing and sales leadership experience in the agricultural industry sector. She has worked for many years with Monsanto and Syngenta. Hoa also the Director of Phu Sa Vegetable Seed and Agricultural Product Trading Co., LTD. With her experienced as a Former Sales and Marketing Director of East West Seed Vietnam Co. and Former SEA Sales Lead of Vegetable Seed Division, Monsanto USA. Previously, Hoa is the Chief of Representative Office in Vietnam for Seminis Vegetable Seed -USA and Product Development Manager of Vegetable Seed Division, Syngenta Vietnam. Previous Next

Go back John L. Warden, Jr. Chairman & Co-Founder Co-Founder, CEO Entrepreneurial and executive roles in 5 start-up companies to date, returning more than $75M in net profits to investors. Successful business development experience with Biovista, a drug development services provider to major pharmaceutical companies. Significant impact building markets for technology products. Developed, engineered and constructed the proprietary software and hardware for the HemChip®, HemBox®, HemStation®. Previous Next

Go back Nha Duong Board member Investor ​ Previous Next

Go back Thomas S. Dann Board member Managing Director, Castlehaven Advisors, LLC Mr. Dann has almost 20 years’ experience in technology investing and company building. He was previously Managing Director of two early stage venture funds, the Maryland Venture Fund and ECentury Capital Partners. He also formerly served as a director of Global Internet Ventures, LLC and as Founder and Managing Director of Castlehaven Advisors, LLC. During his venture career, Mr. Dann served as a director of numerous early stage companies, as well as a Director of the Mid-Atlantic Venture Association. He received a B.A. degree from Stanford University and a Juris Doctorate from American University Law School. Previous Next

Using graphene-based sensors and patented bio preservatives, Hememics brings handheld, lab-quality testing performance wherever needed Our low-cost platform consists of a portable, easy-to-use reader utilizing a single-use biochip with 32 sensors that can be individually programmed to detect molecular, antigen and antibody targets Hem Chip Hem Box Read More Read More Read More *Click on products to learn more* Hem Station ® ® ® We put a whole lab in your hand so you can make decisions when and wherever necessary – simplifying workflows with results within 5 minutes Environmental Hem Box ® and Hem Chip ® are convenient, resilient and reliable. The size of a smartphone and thumb respectively, they are both easily transportable. The BIOSENSOR system is also temperature resistant and ruggedized, making the Hem Box ® and HemChip ® perfect for field use

Go back Hao V. Nguyen Board member Founder & CEO, AMVI Partners, LLC Founder & CEO, Anh Khoa Medical Equipment Co. Mr. Hao Nguyen is an innovator and entrepreneur with 25+ years in business leadership and a specialist in the medical equipment market. He is the Founder and CEO of Anh Khoa Medical Equipment Co., a global import/export company with more than $20M in revenue and the Founder and CEO of AMVI Partners, LLC. Mr. Hao has experienced in all aspects of business formation, operation, finance, and management together with the visionary product developer with deep education in research and analytics trending markets. Mr. Hao is an effective communicator and motivator who identifies and leverages assets in teammates to reach organizational goals. Hao is the relentless optimist who believes there is no failure, only feedback. Previous Next

Go back David Ho, PhD Board member & Founder Founder, President & CSO An acknowledged expert on blood platelets who has been at the forefront of blood research for over a decade. Dr. Ho is well-published and has expanded the understanding of how coagulation protein factor XI interacts with platelets. Inventor of an unique desiccation technique to preserve human cells for extended storage. He has been issued three US patents and numerous scientific awards. Has directed numerous inter-organizational projects with academic, government and industry partners for cellular products in wound dressing, tissue regeneration and transfusable applications. Previous Next

Management Team John L. Warden, Jr. Co-Founder & CEO Learn more Richard Liu CFO Learn more David Ho, PhD Founder, President & CSO Learn more Srivatsa Aithal, PhD Director of R&D Learn more

< Back WE WERE THERE! ADLM (AACC) 2023 conference was held in Anaheim CA Hememics' booth experienced a great amount of traffic and interest from many passerby Hememics team and investors at the booth David Ho, the CSO of Hememics, and John Warden, the CEO of Hememics. Hememics experienced lots of engagement from passerby where they were very interested in the 3 products showcased: the Hem Chip ® , Hem Box ® , and Hem Stati on ® < Back

< Back Go back A Bit About David Ho, PhD Founder, President & CSO An acknowledged expert on blood platelets who has been at the forefront of blood research for over a decade. Dr. Ho is well-published and has expanded the understanding of how coagulation protein factor XI interacts with platelets. Inventor of an unique desiccation technique to preserve human cells for extended storage. He has been issued three US patents and numerous scientific awards. Has directed numerous inter-organizational projects with academic, government and industry partners for cellular products in wound dressing, tissue regeneration and transfusable applications. < Previous Next >

< Back Go back A Bit About Srivatsa Aithal, PhD Director of R&D Sri Aithal pursued his Post-Doc at McMaster University and Ph.D. at Sherbrooke University in Canada. He drove the effort to commercialize impedance spectroscopy-based sensing at Abnova, Taiwan. He was also a Co-Founder of Celerite Labs, a startup company commercializing magnetic bio-printing technology that accelerated drug discovery. Sri has several journal publications and an approved patent. < Previous Next >